Replimune Group, Inc. - COMMON STOCK (REPL)

Historical Holders from Q3 2018 to Q3 2025

Symbol
REPL on Nasdaq
Type / Class
Equity / COMMON STOCK
Shares outstanding
78.4M
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
82.9M
Holdings value
$348M
% of all portfolios
0.001%
Grand Portfolio weight change
0%
Number of holders
160
Number of buys
96
Number of sells
-96
Average Value change %
0%
Average buys %
+0%
Average sells %
-0.003%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Replimune Group, Inc. - COMMON STOCK (REPL)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BAKER BROS. ADVISORS LP 14.3% $100M 11M Baker Bros. Advisors LP 07 Mar 2025
PRICE T ROWE ASSOCIATES INC /MD/ 10.6% $34.8M 8.31M T. Rowe Price Associates, Inc. 30 Sep 2025
RTW INVESTMENTS, LP 8.2% $26.8M 6.4M RTW Investments, LP 30 Sep 2025
Forbion Capital Fund III Cooperatief U.A. 6.1% $38.2M 4.22M Forbion Capital Fund III Cooperatief U.A. 31 Dec 2024
Point72 Asset Management, L.P. 4.7% -16.7% $15.2M -$3.49M 3.63M -18.7% Point72 Asset Management, L.P. 30 Sep 2025
VANGUARD GROUP INC 4.77% $32.5M 3.6M The Vanguard Group 31 Dec 2024
Redmile Group, LLC 0.7% -95% $2.25M -$18.3M 536K -89.1% Redmile Group, LLC 30 Sep 2025

Institutional Holders of Replimune Group, Inc. - COMMON STOCK (REPL)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 82.9M $348M -$50M $4.19 160
2025 Q2 81M $752M -$9.72M $9.29 173
2025 Q1 82M $799M +$36.9M $9.75 165
2024 Q4 77.9M $943M +$80.8M $12.11 155
2024 Q3 69.9M $767M -$7.69M $10.96 143
2024 Q2 70.9M $638M +$37.4M $9.00 148
2024 Q1 67M $547M +$8.62M $8.17 147
2023 Q4 66M $557M -$40.6M $8.43 138
2023 Q3 56.8M $971M +$32.5M $17.11 126
2023 Q2 54.6M $1.27B +$26.6M $23.22 139
2023 Q1 53.8M $949M +$90.9M $17.66 138
2022 Q4 48.2M $1.31B +$189M $27.20 135
2022 Q3 40.8M $704M -$8.66M $17.27 103
2022 Q2 40M $700M +$18M $17.48 98
2022 Q1 39.1M $665M -$35.5M $16.98 104
2021 Q4 38.8M $1.05B +$5.6M $27.10 97
2021 Q3 35.4M $1.05B +$5.53M $29.64 99
2021 Q2 34.9M $1.34B -$5.48M $38.42 109
2021 Q1 34.7M $1.06B +$1.01M $30.51 106
2020 Q4 34.5M $1.32B +$362M $38.15 112
2020 Q3 26.6M $612M +$25.7M $23.02 78
2020 Q2 25.4M $631M +$87.7M $24.85 75
2020 Q1 22.2M $221M -$471K $9.97 56
2019 Q4 22M $316M +$48.2M $14.35 61
2019 Q3 18.6M $258M -$14.8M $13.90 51
2019 Q2 19.6M $287M +$6.76M $14.66 53
2019 Q1 19.1M $291M +$17.7M $15.22 53
2018 Q4 18.2M $182M +$1.49M $10.00 50
2018 Q3 17.9M $289M +$289M $16.10 54